Member Info for spacetec

Nice to see this rise has kept well with current climate, hope something afoot with DOJ outcome

Let's hope good settlement in our favour

Inovio says if the initial human trials are a success, larger trials would follow, ideally in an outbreak setting in China "by the end of the year".

It is impossible to predict whether this outbreak is likely to have ended by then. But if Inovio's timeline goes to plan, the company says it will be the quickest a new vaccine has ever been developed and tested in an outbreak situation.

The last time a similar virus - Sars - emerged in 2002 - China was slow to let the world know what was happening. So by the time work on a vaccine started in earnest, the outbreak was almost over.

At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Hurricane Energ (HUR). If you are looking for stocks with good return, Hurricane Energ can be a profitable investment option. Hurricane Energ quote is equal to 15.027 GBX at 2020-02-24. Based on our forecasts, a long-term increase is expected, the "HUR" stock price prognosis for 2025-02-15 is 40.540 GBX. With a 5-year investment, the revenue is expected to be around +169.78%. Your current $100 investment may be up to $269.78 in 2025.
Current Price: 14.92 GBX

can you imagine that cure for corona virus this would go straight to £2

Historical index on London Stock Exchange : D- "Should I invest in Bids stock?" "Should I trade "BIDS" stock today?" According to our live Forecast System, Bids stock is an awesome long-term (1-year) investment*. "BIDS" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "BIDS" projections.
At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Bids (BIDS). If you are looking for stocks with good return, Bids can be a profitable investment option. Bids quote is equal to 6.380 GBX at 2020-02-24. Based on our forecasts, a long-term increase is expected, the "BIDS" stock price prognosis for 2025-02-15 is 60.578 GBX. With a 5-year investment, the revenue is expected to be around +849.49%. Your current $100 investment may be up to $949.49 in 2025.

lol I think my riddles have done it

hmmm left the first wife now on to second one probably leave her too if i this one goes to 0 value as she not aware money in here lol ouuch

By all means I dont have large holding here as some of you but my 143,143 shares are large enough for me almost 35% of my portfolio

JoeSoap your nearly right lol but its COFFIN

lol Condom offcourse you can feel a condom , people have use for it

Who makes it, has no need of it.
Who buys it, has no use for it.
Who uses it can neither see nor feel it.
What is it?

I know I will sound like complete idiot but 2hrs 40 mins

You got it

A man works on 10th floor , everyday when going home he will use the lift from 10th floor to ground floor ,but when starting work, even if he is running late he will always stop at 7th floor and climb stairs to 10th floor unless he is with someone else in the lift why is that?

Below are the data sources, inputs and calculation used to determine the intrinsic value for Indivior.

LSE:INDV Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 3 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 6.3%
Perpetual Growth Rate 10-Year GB Government Bond Rate 0.5%
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for LSE:INDV
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year GB Govt Bond Rate 0.5%
Equity Risk Premium S&P Global 5.4%
Pharmaceuticals Unlevered Beta Simply Wall St/ S&P Global 0.68
Re-levered Beta = 0.33 + [(0.66 * Unlevered beta) * (1 + (1 - tax rate) (Debt/Market Equity))]
= 0.33 + [(0.66 * 0.683) * (1 + (1 - 21.0%) (77.41%))] 1.068
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm) 1.068
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.53% + (1.068 * 5.44%) 6.34%
Discounted Cash Flow Calculation for LSE:INDV using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Indivior is arrived at by discounting future cash flows to their present value using the 2 stage method. We use analyst's estimates of cash flows going forward 5 years for the 1st stage, the 2nd stage assumes the company grows at a stable rate into perpetuity.

LSE:INDV DCF 1st Stage: Next 5 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 6.34%)
2020 -582.7 Analyst x1 -547.97
2021 91.3 Analyst x2 80.74
2022 184.5 Analyst x2 153.44
2023 324.5 Analyst x2 253.79
2024 510 Analyst x1 375.09
2025 656.52 Est @ 28.73% 454.07
2026 789.58 Est @ 20.27% 513.56
2027 902.87 Est @ 14.35% 552.24
2028 994.98 Est @ 10.2% 572.31
2029 1,067.62 Est @ 7.3% 577.49
Present value of next 5 years cash flows $2,984
LSE:INDV DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $1,067.619 x (1 + 0.53%) ÷ (6.34% - 0.53% ) $18,480.41
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
$18,480 ÷ (1 + 6.34%)10 $9,996.34
LSE:INDV Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $2,984 + $9,996 $12,980.34
Equity Value per Share
(USD) = Total value / Shares Outstanding
= $12,980 / 732 $17.74
LSE:INDV Discount to Share Price
Calculation Result
Exchange Rate USD/GBP
(Reporting currency to currency of LSE:INDV) 0.768
Value per Share
(GBP) = Value per Share in USD x Exchange Rate (USD / GBP)
= $17.74 x 0.77 £13.62
Value per share (GBP) From above. £13.62
Current discount Discount to share price of £0.40
= -1 x (£0.40 - £13.62) / £13.62 97.1%
Learn more about our DCF calculations in Simply Wall

Only it this was true hey, from wallstreet site
Valuation
Is Indivior undervalued compared to its fair value and its price relative to the market?

Analysis Checks 6/6
>50%

Undervalued compared to fair value
Share Price vs. Fair Value
97.1%
Undervalued
Current Price
UK£0.40
Fair Value
UK£13.62
20% Undervalued
About Right
20% Overvalued
View Data
Below Fair Value: INDV (£0.4) is trading below our estimate of fair value (£13.62)

Significantly Below Fair Value: INDV is trading below fair value by more than 20%.

Indivior shares are ‘attractive217;, says Numis Indivior (INDV), maker of addiction treatment drugs, may have reported a £42m loss in the fourth quarter but Numis believes the shares are ‘highly attractive’. Analyst Paul Cuddon retained his ‘buy’ recommendation and target price of 160p on the stock, which tumbled 19.6% to 39.6p yesterday. ‘Indivior continues to lead the battle against the opioid epidemic and has delivered $785m in sales, in line with our expectations and toward the upper end of guidance, which had been upgraded twice during the year,’ he said. ‘The company has also ramped up sales and marketing investment, which has aided performance of [opioid addiction treatment] Sublocade, and sets the product for continued strong growth into full-year 2020. We continue to find the risk-reward highly attractive.’

at 0.07p

I share the same view hold it hard